2024
DOI: 10.1212/wnl.0000000000209324
|View full text |Cite
|
Sign up to set email alerts
|

Noncontrast CT Selected Thrombectomy vs Medical Management for Late-Window Anterior Large Vessel Occlusion

Thanh N. Nguyen,
Raul G. Nogueira,
Muhammad M. Qureshi
et al.

Abstract: Background and ObjectivesThere is uncertainty whether patients with large vessel occlusion (LVO) presenting in the late 6-hour to 24-hour time window can be selected for endovascular therapy (EVT) by noncontrast CT (NCCT) and CT angiography (CTA) for LVO detection. We evaluated the clinical outcomes of patients selected for EVT by NCCT compared with those medically managed in the extended time window. MethodsThis multinational cohort study was conducted at 66 sites across 10 countries. Consecutive patients wit… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 7 publications
(1 citation statement)
references
References 41 publications
0
1
0
Order By: Relevance
“…In the absence of randomized clinical trial data that would establish the efficacy of EVT in complex clinical scenarios, and given the high proportion of patients treated beyond current guideline criteria, 24 , 25 , 26 a more precise estimate of favorable outcomes with EVT for late window patients with LVO is needed. We modeled outcomes associated with EVT versus BMM across a large, heterogeneous cohort to predict a favorable response to treatment using a pragmatic numerical scale.…”
mentioning
confidence: 99%
“…In the absence of randomized clinical trial data that would establish the efficacy of EVT in complex clinical scenarios, and given the high proportion of patients treated beyond current guideline criteria, 24 , 25 , 26 a more precise estimate of favorable outcomes with EVT for late window patients with LVO is needed. We modeled outcomes associated with EVT versus BMM across a large, heterogeneous cohort to predict a favorable response to treatment using a pragmatic numerical scale.…”
mentioning
confidence: 99%